HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

HERBALIFE LTD.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$13.88−0.72 (-4.93%)

Close on Oct 19, 2026

Market cap: $1.45B
P/E (TTM): 9.0
Dividend yield: –

Fundamental chart

Pick a measure to chart its full history

$5.04BFY2025, +2.7% a year since FY2011

Where these numbers come from

Parsed from the XBRL in Herbalife's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on May 15, 2018
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HLF.

Revenue growth5.5% · median -4.2%

Gross margin77.7% · median 28.6%

Operating margin9.5% · median -24.9%

Net margin3.2% · median -33.1%

Company	Revenue	Growth
HLF	$5.20B	+5.5%
PRGO	$4.14B	-4.2%
BRBR	$2.35B	+5.9%
NUS	$1.38B	-15.4%
COSM	$73.73M	+33.8%
NASC	$1.03M	-57.7%

Company

Next earnings (est.): Nov 4, 2026, during market hours
Exchange: NYSE
Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal year ends: December 31
Employees: 8,500
Held by institutions: 100.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1180262

Advertisement
300 × 250